Volume | 8,768 |
|
|||||
News | - | ||||||
Day High | 0.82005 | Low High |
|||||
Day Low | 0.7382 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Qilian International Holding Group Ltd | QLI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.7482 | 0.7382 | 0.82005 | 0.78 | 0.7701 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
69 | 8,768 | $ 0.7701004 | $ 6,752 | - | 0.3551 - 1.2974 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:34:30 | 41 | $ 0.7504 | USD |
Qilian International Holding Group Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
27.89M | 35.75M | - | 46.47M | -7.78M | -0.22 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Qilian News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QLI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.70 | 0.964 | 0.63 | 0.753594 | 738,327 | 0.08 | 11.43% |
1 Month | 0.62 | 0.964 | 0.5214 | 0.7117617 | 451,242 | 0.16 | 25.81% |
3 Months | 0.61 | 0.964 | 0.3551 | 0.6910972 | 174,230 | 0.17 | 27.87% |
6 Months | 0.7303 | 0.964 | 0.3551 | 0.6816776 | 91,502 | 0.0497 | 6.81% |
1 Year | 1.28 | 1.2974 | 0.3551 | 0.6867005 | 46,519 | -0.50 | -39.06% |
3 Years | 4.18 | 4.99 | 0.3551 | 1.88 | 28,694 | -3.40 | -81.34% |
5 Years | 8.01 | 22.00 | 0.3551 | 6.42 | 75,149 | -7.23 | -90.26% |
Qilian Description
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generate most of the revenue. |